Myeloid growth factors should not be administered routinely after allogeneic hematopoietic stem-cell transplantation

Comment

Jayesh Mehta. J Clin Oncol. 2004.

. 2004 Nov 1;22(21):4429-30; author reply 4430-2.

doi: 10.1200/JCO.2004.99.105.

No abstract available

Comment on

Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F. Ringdén O, et al. J Clin Oncol. 2004 Feb 1;22(3):416-23. doi: 10.1200/JCO.2004.06.102. Epub 2003 Dec 22. J Clin Oncol. 2004. PMID: 14691124
Use of granulocyte colony-stimulating factor following hematopoietic cell transplantation: does haste make waste?
Appelbaum FR. Appelbaum FR. J Clin Oncol. 2004 Feb 1;22(3):390-1. doi: 10.1200/JCO.2004.11.963. Epub 2003 Dec 22. J Clin Oncol. 2004. PMID: 14691127 No abstract available.